Charles Schwab’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$34.6M Buy
707,704
+45,630
+7% +$2.23M 0.01% 1334
2025
Q1
$33.7M Sell
662,074
-23,635
-3% -$1.2M 0.01% 1331
2024
Q4
$31M Sell
685,709
-21,021
-3% -$949K 0.01% 1439
2024
Q3
$26.2M Buy
706,730
+47,902
+7% +$1.78M 0.01% 1542
2024
Q2
$20.1M Buy
658,828
+39,535
+6% +$1.21M ﹤0.01% 1678
2024
Q1
$18M Buy
619,293
+8,375
+1% +$244K ﹤0.01% 1674
2023
Q4
$16.8M Buy
610,918
+14,155
+2% +$390K ﹤0.01% 1691
2023
Q3
$13.4M Buy
596,763
+23,288
+4% +$522K ﹤0.01% 1755
2023
Q2
$23.3M Buy
573,475
+15,166
+3% +$617K 0.01% 1388
2023
Q1
$27M Sell
558,309
-1,676
-0.3% -$81.2K 0.01% 1239
2022
Q4
$21.4M Buy
559,985
+12,497
+2% +$477K 0.01% 1378
2022
Q3
$27.5M Buy
547,488
+18,950
+4% +$951K 0.01% 1156
2022
Q2
$21.2M Buy
528,538
+16,158
+3% +$647K 0.01% 1366
2022
Q1
$19.1M Buy
512,380
+13,201
+3% +$493K 0.01% 1585
2021
Q4
$19.9M Buy
499,179
+10,569
+2% +$421K 0.01% 1584
2021
Q3
$18.2M Sell
488,610
-4,298
-0.9% -$160K 0.01% 1662
2021
Q2
$20.8M Buy
492,908
+19,943
+4% +$843K 0.01% 1553
2021
Q1
$22.4M Buy
472,965
+21,964
+5% +$1.04M 0.01% 1435
2020
Q4
$27.5M Buy
451,001
+7,924
+2% +$484K 0.01% 1174
2020
Q3
$20.7M Buy
443,077
+13,032
+3% +$609K 0.01% 1179
2020
Q2
$21.8M Buy
430,045
+46,893
+12% +$2.38M 0.01% 1103
2020
Q1
$17.1M Buy
383,152
+8,038
+2% +$359K 0.01% 1116
2019
Q4
$18M Buy
375,114
+22,566
+6% +$1.08M 0.01% 1284
2019
Q3
$11.9M Buy
352,548
+28,411
+9% +$961K 0.01% 1495
2019
Q2
$14.6M Sell
324,137
-33,294
-9% -$1.5M 0.01% 1362
2019
Q1
$13.5M Buy
357,431
+38,487
+12% +$1.45M 0.01% 1392
2018
Q4
$10.9M Buy
318,944
+36,090
+13% +$1.24M 0.01% 1395
2018
Q3
$13.3M Sell
282,854
-12,781
-4% -$601K 0.01% 1445
2018
Q2
$9.97M Buy
295,635
+72,308
+32% +$2.44M 0.01% 1606
2018
Q1
$6.04M Buy
223,327
+34,839
+18% +$943K ﹤0.01% 1839
2017
Q4
$3.14M Buy
188,488
+9,693
+5% +$162K ﹤0.01% 2140
2017
Q3
$3.58M Buy
178,795
+24,366
+16% +$488K ﹤0.01% 2056
2017
Q2
$2.83M Buy
154,429
+28,668
+23% +$526K ﹤0.01% 2099
2017
Q1
$1.24M Buy
125,761
+6,840
+6% +$67.3K ﹤0.01% 2358
2016
Q4
$1.3M Buy
118,921
+6,160
+5% +$67.2K ﹤0.01% 2345
2016
Q3
$1.58M Buy
112,761
+53,740
+91% +$753K ﹤0.01% 2248
2016
Q2
$415K Sell
59,021
-41,765
-41% -$294K ﹤0.01% 2656
2016
Q1
$650K Sell
100,786
-3,763
-4% -$24.3K ﹤0.01% 2478
2015
Q4
$3.39M Buy
104,549
+6,828
+7% +$221K ﹤0.01% 1767
2015
Q3
$2.61M Buy
97,721
+13,469
+16% +$360K ﹤0.01% 1908
2015
Q2
$4.06M Buy
84,252
+15,824
+23% +$762K 0.01% 1688
2015
Q1
$4.16M Buy
68,428
+2,930
+4% +$178K 0.01% 1633
2014
Q4
$3.39M Buy
65,498
+7,145
+12% +$370K 0.01% 1705
2014
Q3
$2.57M Buy
58,353
+8,093
+16% +$356K ﹤0.01% 1820
2014
Q2
$1.31M Buy
50,260
+15,474
+44% +$405K ﹤0.01% 2203
2014
Q1
$910K Buy
34,786
+14,195
+69% +$371K ﹤0.01% 2336
2013
Q4
$350K Buy
20,591
+648
+3% +$11K ﹤0.01% 2723
2013
Q3
$447K Buy
+19,943
New +$447K ﹤0.01% 2593